Perdoceo Education (PRDO) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Q2 2024 results exceeded expectations, driven by strong student retention and engagement at both CTU and AIUS, with operational improvements and technology investments supporting performance.
Total student enrollments rose 4.2% year-over-year, with CTU up 14.7% and AIUS down 18.2%, reflecting operational changes at AIUS and growth at CTU.
Announced a definitive agreement to acquire the University of St. Augustine for Health Sciences for $142–$144 million in cash, expected to diversify offerings and be accretive to adjusted operating income in 2025.
Quarterly dividend increased by 18.2% to $0.13 per share, the first increase since policy implementation, reflecting confidence in financial position.
Financial highlights
Q2 2024 revenue was $166.7 million, down 10.6% year-over-year; YTD revenue was $335.0 million, down 12.3%.
Q2 net income was $38.4 million ($0.57 per diluted share), down 29.7% year-over-year; adjusted EPS was $0.60.
Q2 operating income was $46.0 million (27.6% margin), down 4.3% year-over-year; adjusted operating income was $50.9 million.
Ended Q2 with $675.2 million in cash, equivalents, and short-term investments.
Year-to-date net cash flows from operations were $93.0 million, up from $66.2 million in the prior year.
Outlook and guidance
Full-year 2024 adjusted operating income expected between $179 million and $190 million; adjusted EPS projected at $2.13–$2.25.
Q3 2024 adjusted operating income expected at $45–$47 million, with adjusted EPS of $0.50–$0.54.
Revenue at CTU and AIUS expected to be lower for the full year, but enrollment growth and improved retention anticipated to offset declines by year-end; AIUS expected to return to enrollment growth by year-end 2024.
Effective tax rate for full year 2024 projected between 26.5% and 27.5%.
Latest events from Perdoceo Education
- 2025 saw double-digit growth in revenue, income, and enrollments, with strong 2026 guidance issued.PRDO
Q4 202519 Feb 2026 - Enrollment up 11%, revenue down 5.6%, margins and outlook improve; acquisition closing soon.PRDO
Q3 202414 Jan 2026 - Q1 2025 revenue up 26.6% to $213M, driven by USAHS acquisition and enrollment growth.PRDO
Q1 202526 Dec 2025 - Q4 2024 saw record revenue and operating income, with 2025 set for further growth post-acquisition.PRDO
Q4 202423 Dec 2025 - Annual meeting to vote on directors, pay, and auditor amid growth, governance, and ESG focus.PRDO
Proxy Filing2 Dec 2025 - Annual meeting to vote on directors, executive pay, and auditor ratification.PRDO
Proxy Filing2 Dec 2025 - Q2 2025 revenue and enrollments surged, with higher dividends and a new $75M buyback program.PRDO
Q2 202516 Nov 2025 - Q3 2025 delivered strong revenue, income, and enrollment growth, with robust shareholder returns.PRDO
Q3 20255 Nov 2025